Quantum Biopharma (QNTM) Notes Payables (2019 - 2026)
Quantum Biopharma (QNTM) reported Notes Payables of $300549.0 for Q1 2026, down 72.37% on a YoY basis from $1.1 million in Q1 2025, and down 76.89% sequentially from $1.3 million in Q4 2025.
Quantum Biopharma (QNTM) Notes Payables (2019 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 8 years of Notes Payables data on file, last reported at $300549.0 in Q1 2026.
- For the quarter ending Q1 2026, Notes Payables fell 72.37% year-over-year to $300549.0; the trailing twelve-month figure through Mar 2026 stood at $300549.0 (down 72.37% YoY), and the FY2025 full-year result was $1.3 million, up 110.1% from the prior year.
- Notes Payables eased to $300549.0 in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $2.0 million in Q3 2025 to a low of $300549.0 in Q1 2022.
- A 5-year average of $683187.2 and a median of $300549.0 in 2022 frame the typical range for Notes Payables.
- Across the five-year window, Notes Payables jumped 557.23% in 2025 and tumbled 72.37% in 2026, its largest moves.
- Tracing QNTM's Notes Payables over 5 years: stood at $300549.0 in 2022, then changed by 0.0% to $300549.0 in 2023, then jumped by 105.97% to $619029.0 in 2024, then jumped by 110.1% to $1.3 million in 2025, then tumbled by 76.89% to $300549.0 in 2026.
- Business Quant data shows QNTM's Notes Payables at $300549.0 in Q1 2026, $1.3 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Quantum Biopharma | 13.00 Bn | 13.00 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,549.00 |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 1.09 Mn |
| Dec 31, 2024 | 619,029.00 |
| Sep 30, 2024 | 300,549.00 |
| Jun 30, 2024 | 615,562.00 |
| Sep 30, 2023 | 300,549.00 |
| Jun 30, 2023 | 300,549.00 |
| Mar 31, 2023 | 300,549.00 |
| Dec 31, 2022 | 300,549.00 |
| Sep 30, 2022 | 300,549.00 |
| Jun 30, 2022 | 300,549.00 |
| Mar 31, 2022 | 300,549.00 |
| Dec 31, 2021 | 300,549.00 |
| Sep 30, 2021 | 300,549.00 |
| Jun 30, 2021 | 300,549.00 |
| Mar 31, 2021 | 358,549.00 |
| Dec 31, 2020 | 384,647.00 |